| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/01/2014 | CN102239179B Integrin peptide, anti-cd 18 beta A antibody for treatment of endotoxin-mediated pro-inflammatory responses and the use |
| 01/01/2014 | CN101821403B Cell for use in the production of exogenous protein, and production process using the cell |
| 01/01/2014 | CN101553500B GnRH peptide derivative (gonadotropin-releasing hormone) |
| 12/31/2013 | US8618283 Ligand libraries for screening GPCRs |
| 12/31/2013 | US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 12/31/2013 | US8618267 PEG-urate oxidase conjugates and use thereof |
| 12/31/2013 | US8618266 Hasylated polypeptides |
| 12/31/2013 | US8618258 Freeze-dried fibrin matrices and methods for preparation thereof |
| 12/31/2013 | US8618257 Modified human plasma polypeptide or Fc scaffolds and their uses |
| 12/31/2013 | US8618256 Cysteine variants of interferon gamma |
| 12/31/2013 | US8618254 Inhibition of AXL signaling in anti-metastatic therapy |
| 12/31/2013 | US8618247 Peptide, use of the peptide, method for the production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 12/31/2013 | US8618152 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 12/31/2013 | US8618148 Use of telmisartan for the prevention and treatment of vascular headache |
| 12/31/2013 | US8618066 Coating compositions having peptidic antimicrobial additives and antimicrobial additives of other configurations |
| 12/31/2013 | US8618065 Cyclosporin derivatives |
| 12/31/2013 | US8618064 Methods of providing therapeutic effects using cyclosporin components |
| 12/31/2013 | US8618063 Method for treating a synucleinopathy |
| 12/31/2013 | US8618062 Method of modulating integrin mediated cellular activity and agents useful for same |
| 12/31/2013 | US8618061 Methods for reducing oxidative damage |
| 12/31/2013 | US8618060 Metallothionein-derived peptide fragments |
| 12/31/2013 | US8618058 Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity |
| 12/31/2013 | US8618057 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid |
| 12/31/2013 | US8618056 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 12/31/2013 | US8618055 Prominin-1 peptide fragments and uses thereof |
| 12/31/2013 | US8618054 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 12/31/2013 | US8618053 FGF21 mutants multimers and uses thereof |
| 12/31/2013 | US8618052 Method of treating coronary artery disease by administering FGF-5 |
| 12/31/2013 | US8618051 Vesiculins |
| 12/31/2013 | US8618050 Lipid preparation for enhancing mineral absorption |
| 12/31/2013 | US8618049 Ester insulin |
| 12/31/2013 | US8618048 Insulin analogues of prolonged activity |
| 12/31/2013 | US8618047 Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions |
| 12/31/2013 | US8618046 Treatment of atherosclerosis with cholesterol ester transport protein mimotopes |
| 12/31/2013 | US8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| 12/31/2013 | US8618044 Thrombopoietic compounds |
| 12/31/2013 | US8618043 Use of ADNF polypeptides for treating anxiety and depression |
| 12/31/2013 | US8617894 Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
| 12/31/2013 | US8617867 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 12/31/2013 | US8617841 Protein and production process and use thereof |
| 12/31/2013 | US8617840 Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes |
| 12/31/2013 | US8617828 Glutathione S-transferase omega 1 wild type specific antibody |
| 12/31/2013 | US8617810 Screening method for compounds that promote differentiation of inner ear progenitor cells |
| 12/31/2013 | US8617802 Organ transplant solutions and method for transplanting organs |
| 12/31/2013 | US8617615 Charged lipoprotein complexes and their uses |
| 12/31/2013 | US8617613 Polymer-based sustained release device |
| 12/31/2013 | US8617573 Botulinum neurotoxin B receptors and use thereof |
| 12/31/2013 | US8617566 Composition comprising VLP and amyloid beta peptide |
| 12/31/2013 | US8617560 Peptides for vaccination against human CMV |
| 12/31/2013 | US8617553 Use of goat serum for veterinary treatment |
| 12/31/2013 | US8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies |
| 12/31/2013 | US8617545 Methods for use with BAFF antagonists |
| 12/31/2013 | US8617543 Modified mutant collagenase and its use in fat melting and in scar reduction |
| 12/31/2013 | US8617542 DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof |
| 12/31/2013 | US8617540 Combinational chemotherapy treatment |
| 12/31/2013 | US8617539 Method of administration of platelet-rich plasma to treat an acute cardiac dysfunction |
| 12/31/2013 | US8617532 Therapeutic use of interferon-polymer conjugates |
| 12/31/2013 | US8617531 Methods of making proteins and peptides containing a single free cysteine |
| 12/31/2013 | CA2722364C Melanoma antigens |
| 12/31/2013 | CA2579884C Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 12/31/2013 | CA2548454C Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 12/31/2013 | CA2543817C Fibroblast-mobilization agent containing a g-csf for repair of myocardial infarct lesion |
| 12/31/2013 | CA2543257C Methods and compositions for delivering polynucleotides |
| 12/31/2013 | CA2542269C Fusion molecules comprising antigens and mhc i or ii cytoplasmic domains |
| 12/31/2013 | CA2485847C Glucan-based vaccines |
| 12/31/2013 | CA2467908C Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages |
| 12/31/2013 | CA2426030C Methods of treating disorders related to apoe |
| 12/31/2013 | CA2421584C Gene therapy for cardiac arrythmias |
| 12/31/2013 | CA2246768C Uses of gdnf and gdnf receptor |
| 12/27/2013 | WO2013192364A1 Treatments of oxidative stress conditions |
| 12/27/2013 | WO2013192238A2 Compositions and methods for treatment of diabetes |
| 12/27/2013 | WO2013192224A1 Synergistic combination for treating a cancer |
| 12/27/2013 | WO2013192163A1 Gluten-related disorders |
| 12/27/2013 | WO2013191569A1 Anti-inflammatory proteins and peptides and methods of preparation and use thereof |
| 12/27/2013 | WO2013191509A1 Pharmaceutical composition for preventing and treating parkinson's disease, containing n-terminal truncated ubiquitin c-terminal hydrolase-l1 (nt-uch-l1) as active ingredient |
| 12/27/2013 | WO2013191459A1 Polyvalent pneumococcal polysaccharide-protein conjugate composition |
| 12/27/2013 | WO2013191352A1 New uses of modified human tumor necrosis factor receptor-1 polypeptide |
| 12/27/2013 | WO2013191280A1 Agent for treating or preventing systemic inflammatory response syndrome |
| 12/27/2013 | WO2013191225A1 Mucosal immunity-stimulating agent, and oral pharmaceutical composition for treating hpv infection |
| 12/27/2013 | WO2013191187A1 Adhesive preparation composition obtained by blending drug, organic solvent, lipophilic ointment base, and powder |
| 12/27/2013 | WO2013190520A2 Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| 12/27/2013 | WO2013190516A1 Modification of the immunomodulatory effects of cells |
| 12/27/2013 | WO2013190443A1 Anti-mullerian hormone |
| 12/27/2013 | WO2013190014A1 Improved cd31 peptides |
| 12/27/2013 | WO2013189988A1 Tablet formulation comprising a peptide and a delivery agent |
| 12/27/2013 | WO2013189606A2 Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 12/27/2013 | WO2013189287A1 Use of interferon in treatment/prevention of tumors resistant to conventional anti-tumor therapy |
| 12/27/2013 | WO2013189282A1 Polypeptide-medicine-slow-releasing microsphere preparation and preparation method therefor |
| 12/27/2013 | WO2013158773A3 Rnase 7 antimicrobial peptides |
| 12/27/2013 | WO2013088371A3 Use of the mmp-12 protein in the prevention and/or treatment of dandruff conditions of the scalp |
| 12/27/2013 | WO2013088370A3 Use of the protein mmp-12 in the prevention and/or treatment of sensitive skin |
| 12/27/2013 | CA2877648A1 Polyvalent pneumococcal polysaccharide-protein conjugate composition |
| 12/27/2013 | CA2876963A1 Gluten-related disorders |
| 12/27/2013 | CA2875454A1 Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder |
| 12/26/2013 | US20130347146 Gntiii expression in plants |
| 12/26/2013 | US20130345409 Growth factor |
| 12/26/2013 | US20130345321 Genipin cross-linked fibrin gels |
| 12/26/2013 | US20130345154 Gap Junction-Enhancing Agents for Treatment of Necrotizing Enterocolitis and Inflammatory Bowel Disease |
| 12/26/2013 | US20130345153 Topical preventative medicament against burns-related systemic inflammatory response syndrome |
| 12/26/2013 | US20130345149 Silicone-based ophthalmic formulations |